Cargando…

Gut-lung axis and dysbiosis in COVID-19

COVID-19, a novel infectious disease, caused by SARS-CoV-2, affected millions of people around the world with a high mortality rate. Although SARS-CoV-2 mainly causes lung infection, gastrointestinal symptoms described in COVID-19 patients and detection of the viral RNA in feces of infected patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	AKTAS, Busra, ASLIM, Belma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Scientific and Technological Research Council of Turkey 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314510/ https://www.ncbi.nlm.nih.gov/pubmed/32595361 http://dx.doi.org/10.3906/biy-2005-102

Ejemplares similares

Neuropathy in COVID-19 associated with dysbiosis-related inflammation
por: AKTAS, Busra, et al.
Publicado: (2021)

Gut Microbiota Dysbiosis and COVID-19: Possible Links
por: Aktas, Busra
Publicado: (2022)

The relationship between the structural characteristics of lactobacilli-EPS and its ability to induce apoptosis in colon cancer cells in vitro
por: Tukenmez, Ummugulsum, et al.
Publicado: (2019)

The relationship of early- and late-onset Alzheimer’s disease genes with COVID-19
por: Sirin, Seda, et al.
Publicado: (2022)

Dissimilarity of the gut–lung axis and dysbiosis of the lower airways in ventilated preterm infants
por: Gallacher, David, et al.
Publicado: (2020)

The lung–gut axis during viral respiratory infections: the impact of gut dysbiosis on secondary disease outcomes
por: Sencio, Valentin, et al.
Publicado: (2021)

Characterization of lactic acid bacteria derived exopolysaccharides for use as a defined neuroprotective agent against amyloid beta(1–42)-induced apoptosis in SH-SY5Y cells
por: Sirin, Seda, et al.
Publicado: (2020)

Intestinal Dysbiosis and the Developing Lung: The Role of Toll-Like Receptor 4 in the Gut-Lung Axis
por: Wedgwood, Stephen, et al.
Publicado: (2020)

Gut Dysbiosis in Children with Cystic Fibrosis: Development, Features and the Role of Gut–Lung Axis on Disease Progression
por: Testa, Ilaria, et al.
Publicado: (2022)

COVID-19 and gut dysbiosis, understanding the role of probiotic supplements in reversing gut dysbiosis and immunity
por: Aldhafiri, Fahad K.
Publicado: (2022)

Gut-Lung Axis in COVID-19
por: Allali, Imane, et al.
Publicado: (2021)

Dysbiosis of the Gut Microbiome in Lung Cancer
por: Zhuang, He, et al.
Publicado: (2019)

The Gut–Organ Axis within the Human Body: Gut Dysbiosis and the Role of Prebiotics
por: Saxami, Georgia, et al.
Publicado: (2023)

Proteomics analysis of the gut–brain axis in a gut microbiota-dysbiosis model of depression
por: Liu, Yiyun, et al.
Publicado: (2021)

Gut-Thyroid axis: How gut microbial dysbiosis associated with euthyroid thyroid cancer
por: Ishaq, Hafiz Muhammad, et al.
Publicado: (2022)

The Role of Gut–Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC
por: Song, Qian, et al.
Publicado: (2022)

The Role of Gut Dysbiosis in the Bone–Vascular Axis in Chronic Kidney Disease
por: Evenepoel, Pieter, et al.
Publicado: (2020)

Antibiotic-Induced Dysbiosis of the Gut Microbiota Impairs Gene Expression in Gut-Liver Axis of Mice
por: Liu, Pu, et al.
Publicado: (2023)

In silico identification of SARS-CoV-2 cell entry inhibitors from selected natural antivirals
por: Şimşek, Yusuf, et al.
Publicado: (2021)

Antiproliferative, neurotoxic, genotoxic and mutagenic effects of toxic cyanobacterial extracts
por: Andeden, Enver Ersoy, et al.
Publicado: (2018)

Oral-Gut-Brain Axis in Experimental Models of Periodontitis: Associating Gut Dysbiosis With Neurodegenerative Diseases
por: Sansores-España, Luis Daniel, et al.
Publicado: (2021)

Dysbiosis of Gut Microbiota from the Perspective of the Gut–Brain Axis: Role in the Provocation of Neurological Disorders
por: Kandpal, Meenakshi, et al.
Publicado: (2022)

Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson’s Disease
por: Kaur, Gagandeep, et al.
Publicado: (2021)

Current Research on the Pathogenesis of NAFLD/NASH and the Gut–Liver Axis: Gut Microbiota, Dysbiosis, and Leaky-Gut Syndrome
por: Kobayashi, Takashi, et al.
Publicado: (2022)

The pathophysiological mechanisms of COVID-19 and host immunity, with emphasis on the dysbiosis of the lung and gut microbiomes and pregnancy
por: Asai, Nobuhiro, et al.
Publicado: (2022)

The gut dysbiosis-cancer axis: illuminating novel insights and implications for clinical practice
por: Asseri, Amer H., et al.
Publicado: (2023)

Gut Dysbiosis during COVID-19 and Potential Effect of Probiotics
por: Hung, Yuan-Pin, et al.
Publicado: (2021)

Dysbiosis of the Gut Microbiome Is Associated With Histopathology of Lung Cancer
por: Qin, Xiong, et al.
Publicado: (2022)

Gut Microbial Alteration in MPTP Mouse Model of Parkinson Disease is Administration Regimen Dependent
por: Aktas, Busra
Publicado: (2023)

Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID
por: Ancona, Giuseppe, et al.
Publicado: (2023)

The developing gut-lung axis: post-natal growth restriction, intestinal dysbiosis and pulmonary hypertension in a rodent model
por: Wedgwood, Stephen, et al.
Publicado: (2019)

Gut-joint axis: Gut dysbiosis can contribute to the onset of rheumatoid arthritis via multiple pathways
por: Romero-Figueroa, María del Socorro, et al.
Publicado: (2023)

Microbiota Modulation of the Gut-Lung Axis in COVID-19
por: de Oliveira, Gislane Lelis Vilela, et al.
Publicado: (2021)

Gut Dysbiosis and IL-21 Response in Patients with Severe COVID-19
por: Khan, Mahejibin, et al.
Publicado: (2021)

Gut–Skin Axis: Current Knowledge of the Interrelationship between Microbial Dysbiosis and Skin Conditions
por: De Pessemier, Britta, et al.
Publicado: (2021)

The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease
por: Abdelbary, Mohamed M. H., et al.
Publicado: (2022)

Gut Microbiota Dysbiosis in COVID-19: Modulation and Approaches for Prevention and Therapy
por: Martín Giménez, Virna Margarita, et al.
Publicado: (2023)

Dysbiosis of the gut and lung microbiome has a role in asthma
por: Hufnagl, Karin, et al.
Publicado: (2020)

Dysbiosis of the Gut Microbiome is associated with Tumor Biomarkers in Lung Cancer
por: Liu, Fang, et al.
Publicado: (2019)

Sialic acid exacerbates gut dysbiosis-associated mastitis through the microbiota-gut-mammary axis by fueling gut microbiota disruption
por: Zhao, Caijun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u9770gc1dvocbfhke9n94tp05n